Try our beta test site
45 studies found for:    Open Studies | "Cholangitis"
Show Display Options
Download search resultsDownload the search results for:
Open Studies | "Cholangitis" (45 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Recruiting The Necessity of Bile Cultures in Patients With Acute Cholangitis
Condition: Acute Cholangitis
Intervention: Other: Ignoring result of bile culture
2 Not yet recruiting Antibiotics to Decrease Post ERCP Cholangitis
Condition: Cholangitis
Interventions: Drug: Ceftriaxone;   Drug: Levofloxacin
3 Recruiting Quality of Life in Patients With Primary Sclerosing Cholangitis
Condition: Primary Sclerosing Cholangitis
Intervention: Other: quality of life survey
4 Recruiting Fecal Microbiota Transplantation for the Treatment of Primary Sclerosing Cholangitis.
Condition: Sclerosing Cholangitis
Intervention: Biological: Fecal Microbiota Transplantation
5 Recruiting PERSEUS: Preliminary Efficacy and Safety of Cenicriviroc in Adult Subjects With Primary Sclerosing Cholangitis
Condition: Primary Sclerosing Cholangitis
Intervention: Drug: Cenicriviroc 150 mg
6 Recruiting Safety and Efficacy Study of Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis
Condition: Primary Sclerosing Cholangitis
Intervention: Drug: ursodeoxycholic acid (UDCA)
7 Recruiting A Trial of BTT1023 in Patients With Primary Sclerosing Cholangitis
Condition: Primary Sclerosing Cholangitis
Intervention: Drug: BTT1023
8 Recruiting Safety, Tolerability, and Efficacy of GS 9674 in Adults With Primary Biliary Cholangitis Without Cirrhosis
Condition: Primary Biliary Cholangitis
Interventions: Drug: GS-9674;   Drug: Placebo to match GS-9674
9 Not yet recruiting A Study of Oral Hymecromone to Treat Adults With Primary Sclerosing Cholangitis
Condition: Primary Sclerosing Cholangitis
Intervention: Drug: hymecromone
10 Recruiting Mitomycin C Therapy for Patients With Primary Sclerosing Cholangitis
Condition: Primary Sclerosing Cholangitis
Interventions: Drug: Mitomycin C;   Drug: Normal saline
11 Recruiting Effect and Safety of Oral Vancomycin in Primary Sclerosing Cholangitis Patients
Condition: Primary Sclerosing Cholangitis
Interventions: Drug: Vancomycin;   Drug: Placebo
12 Not yet recruiting A Study Evaluating the Safety and Efficacy of Curcumin in Patients With Primary Sclerosing Cholangitis
Condition: Primary Sclerosing Cholangitis
Intervention: Drug: Curcumin
13 Recruiting Safety, Tolerability, and Efficacy of GS-9674 in Adults With Primary Sclerosing Cholangitis Without Cirrhosis
Condition: Primary Sclerosing Cholangitis
Interventions: Drug: GS-9674;   Drug: Placebo to match GS-9674
14 Recruiting Factors Associated With Increased Risk of Bacteremia and Cholangitis in ERCP With Cholangioscopy
Conditions: Cholangitis;   Bacteremia
Intervention: Procedure: Cholangioscopy
15 Recruiting Secondary Sclerosing Cholangitis in Critically Ill Patients
Condition: Secondary Sclerosing Cholangitis
Intervention:
16 Recruiting A Multi-part, Double Blind Study to Assess Safety, Tolerability and Efficacy of LJN452 in PBC Patients
Condition: Primary Biliary Cholangitis
Interventions: Drug: LJN452;   Drug: Placebo
17 Recruiting Bile Usefulness for Detecting IgG4-related Sclerosing Cholangitis
Conditions: IgG4-related Sclerosing Cholangitis;   IgG4-related Disease
Intervention:
18 Recruiting Genomics of Primary Sclerosing Cholangitis (PSC)
Condition: Primary Sclerosing Cholangitis (PSC)
Intervention: Genetic: Genetic Analysis
19 Recruiting Registry Trial to Determine pCLE Image Interpretation Criteria and Preliminary Accuracy for PSC Biliary Strictures
Condition: Primary Sclerosing Cholangitis
Intervention: Device: probe based confocal laser endomicroscopy
20 Recruiting Treating Primary Sclerosing Cholangitis and Biliary Atresia With Vancomycin
Conditions: Primary Sclerosing Cholangitis;   Biliary Atresia
Intervention: Drug: Oral Vancomycin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.